Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    13%
    Check dated 2025-10-05T09:34:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:11:57.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Only the revision tag was updated from v3.0.1 to v3.0.2. No other content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-13T17:38:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-06T15:21:23.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant changes with the addition of a facility name and location, while several location-related terms and the previous revision number have been removed.
    Difference
    4%
    Check dated 2025-08-30T12:02:04.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:42:39.000Z thumbnail image

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.